The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the patient's heart.

April 14, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received ... heart disease and these patients ...

Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...

Edwards Lifesciences Corporation, leading global structural heart innovation company, announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark ... most common form of ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received ... common form of valvular heart disease and these patients suffer ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

Researchers at UCL have tested a new scoring system to measure the risk of stroke in patients with narrowed arteries due to ...

Atherosclerosis of the extracranial internal carotid artery (ICA) causes 10–20% of ischaemic strokes.1 As luminal stenosis of the ICA grows, the risk of ischaemic stroke increases,2 and removal of the ...

Diseases are abnormal conditions that have a specific set of signs and symptoms. Diseases can have an external cause, such as an infection, or an internal cause, such as autoimmune diseases. We ...

Despite having a robust drug development pipeline, lupus remains far behind other rheumatic and autoimmune conditions for which dozens of targeted therapies have been developed. Addressing the ...

--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for ... is the most common form of valvular ...